
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Keywords: مهار کننده تیروزین کیناز; BCR-ABL1 mutations; Dasatinib; Imatinib; Nilotinib; Tyrosine kinase inhibitor;